Anti-PTEN/ 10q23del/ BZS monoclonal antibody

Anti-PTEN/ 10q23del/ BZS antibody for FACS & in-vivo assay

Target products collectionGo to PTEN/PTEN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T38257-Ab-1/ GM-Tg-hg-T38257-Ab-2Anti-Human PTEN monoclonal antibodyHuman
GM-Tg-rg-T38257-Ab-1/ GM-Tg-rg-T38257-Ab-2Anti-Rat PTEN monoclonal antibodyRat
GM-Tg-mg-T38257-Ab-1/ GM-Tg-mg-T38257-Ab-2Anti-Mouse PTEN monoclonal antibodyMouse
GM-Tg-cynog-T38257-Ab-1/ GM-Tg-cynog-T38257-Ab-2Anti-Cynomolgus/ Rhesus macaque PTEN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T38257-Ab-1/ GM-Tg-felg-T38257-Ab-2Anti-Feline PTEN monoclonal antibodyFeline
GM-Tg-cang-T38257-Ab-1/ GM-Tg-cang-T38257-Ab-2Anti-Canine PTEN monoclonal antibodyCanine
GM-Tg-bovg-T38257-Ab-1/ GM-Tg-bovg-T38257-Ab-2Anti-Bovine PTEN monoclonal antibodyBovine
GM-Tg-equg-T38257-Ab-1/ GM-Tg-equg-T38257-Ab-2Anti-Equine PTEN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T38257-Ab-1/ GM-Tg-hg-T38257-Ab-2; GM-Tg-rg-T38257-Ab-1/ GM-Tg-rg-T38257-Ab-2;
GM-Tg-mg-T38257-Ab-1/ GM-Tg-mg-T38257-Ab-2; GM-Tg-cynog-T38257-Ab-1/ GM-Tg-cynog-T38257-Ab-2;
GM-Tg-felg-T38257-Ab-1/ GM-Tg-felg-T38257-Ab-2; GM-Tg-cang-T38257-Ab-1/ GM-Tg-cang-T38257-Ab-2;
GM-Tg-bovg-T38257-Ab-1/ GM-Tg-bovg-T38257-Ab-2; GM-Tg-equg-T38257-Ab-1/ GM-Tg-equg-T38257-Ab-2
Products NameAnti-PTEN monoclonal antibody
Formatmab
Target NamePTEN
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PTEN benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PTEN/ 10q23del/ BZS VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMAD000006human PTEN Adenovirus particle
    ORF Viral VectorpGMAD000006human PTEN Adenovirus plasmid
    ORF Viral VectorvGMLV000452human PTEN Lentivirus particle
    ORF Viral VectorpGMLV000452human PTEN Lentivirus plasmid
    ORF Viral VectorpGMAD000353rat Pten Adenovirus plasmid
    ORF Viral VectorpGMAAV000222Norway rat Pten AAV plasmid
    ORF Viral VectorvGMAD000353rat Pten Adenovirus particle
    ORF Viral VectorvGMAAV000222Norway rat Pten AAV particle


    Target information

    Target IDGM-T38257
    Target NamePTEN
    Gene ID5728,19211,50557,705121,403832,101091813,540786,100062388
    Gene Symbol and Synonyms10q23del,2310035O07Rik,A130070J02Rik,B430203M17Rik,BZS,CWS1,DEC,GLM2,MHAM,Mmac,MMAC1,PTEN,PTEN1,PTENbeta,TEP1
    Uniprot AccessionP60484,O54857,P60483
    Uniprot Entry NamePTEN_HUMAN,O54857_RAT,PTEN_CANLF
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000171862
    Target ClassificationTumor-associated antigen (TAA)

    The target: PTEN, gene name: PTEN, also named as 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC11, PTENbeta, TEP1, PTEN. This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.